9 results match your criteria: "S. L. Raheja - Fortis Associate Hospital[Affiliation]"
Does prior transurethral resection of prostate have a negative impact on the outcome of holmium laser enucleation of prostate? Results from a prospective comparative study.
Urol Ann
February 2022
Department of Urology, University of Miami, Miller School of Medicine, Miami, Florida, USA.
Article Synopsis
- This study looked at how safe and effective a laser surgery called HoLEP is for men who still have problems after earlier prostate surgery (TURP).
- They compared two groups of patients: one group had the earlier surgery and then HoLEP, while the other group did not have the earlier surgery.
- The results showed that having the earlier surgery didn't make the new laser surgery harder or less effective, meaning HoLEP works well even after TURP.
A prospective evaluation of high- and low-power holmium laser settings for transurethral lithotripsy in the management of adults with large bladder calculi.
World J Urol
September 2021
Department of Urology, Miller School of Medicine, University of Miami, Miami, USA.
Purpose: To prospectively investigate the efficacy and safety of high-power (100 W) vs low-power (20 W) laser settings for transurethral laser lithotripsy in the management large vesical calculi (> 4 cm).
Methods: All patients with vesical calculi > 4 cm in the maximum dimension and scheduled for transurethral holmium laser lithotripsy were invited to participate in the study. Every alternate patient was treated with either the low- or high-power laser settings.
Simultaneous Holmium Laser Enucleation of Prostate with Removal of the Permanent Prostatic Urethral Stent Using the High-Power Holmium Laser: Technique in Two Cases and Review of the Literature.
J Endourol Case Rep
December 2020
Department of Urology, Miller School of Medicine, University of Miami, Coral Gables, Florida, USA.
Although the prostatic urethral stents are no longer used in the United States for treatment of prostatomegaly, urologists will encounter patients with complications of previously placed permanent prostatic stents. We report two cases of persistent bothersome lower urinary tract symptoms (LUTS) after prostatic stent placement treated with simultaneous holmium laser enucleation of prostate (HoLEP) with endoscopic removal of the prostatic urethral stent using high-power holmium laser. We also reviewed the literature regarding the removal of prostatic stents with holmium laser combined with surgical management of benign prostatic hyperplasia.
View Article and Find Full Text PDFPurpose: To report the results of a randomized controlled trial comparing outcomes between medium power (MP) and high power (HP) laser settings for HoLEPs.
Methods: The primary objective was to compare the enucleation efficiency (EE) of HP- HoLEP (80-100 W) with MP-HoLEP (50 - 60 W). The secondary objectives were to compare treatment efficacy and safety between both groups.
Holmium Laser Enucleation of Prostate Within 6 Weeks of Transrectal Ultrasound Guided Prostate Biopsy is Safe and Effective.
Urology
February 2021
Miller School of Medicine, University of Miami, Miami, FL; S. L. Raheja (Fortis Associate Hospital), Mumbai, India. Electronic address:
Objective: To evaluate the safety and efficacy of performing Holmium laser enucleation of the prostate (HoLEP) for the treatment of bladder outlet obstruction secondary to an enlarged prostate within 6-weeks of a transrectal ultrasound (TRUS) guided prostate biopsy.
Materials And Methods: We performed a retrospective review of patients who underwent a HoLEP at our institution, excluding any patients with a confounding urologic history and compared patients who underwent a TRUS-guided 6- or 12-core prostate biopsy, and then underwent a HoLEP within 6 weeks (study group) with all other patients (control group). Our primary outcomes were enucleation efficiency (EE) and perioperative complication rate.
Authors' Reply: Arterial spin labeling: Clarifying the apparent contradiction.
Neurol India
August 2019
Wipro GE Healthcare, Bengalaru, Karnataka, India.
fosfomycin susceptibility against carbapenem-resistant or extended-spectrum beta-lactamase-producing gram-negative fosfomycin-naive uropathogens: An alluring option or an illusion.
Indian J Med Microbiol
June 2018
Department of Microbiology, S. L. Raheja - Fortis Associate Hospital, Mumbai, Maharashtra, India.
Arterial spin labelling: A novel promising perfusion technique - Can it be a replacement to dynamic susceptibility contrast MRI ?
Neurol India
July 2019
S.L. Raheja - Fortis Associate Hospital, Mumbai, Maharashtra, India.
The Influence of Body Mass Index on Outcomes in Ureteroscopy: Results from the Clinical Research Office of Endourological Society URS Global Study.
J Endourol
January 2017
2 Department of Urology, AMC University Hospital, Amsterdam, The Netherlands .
Introduction: Although ureteroscopy (URS) has been established as a viable treatment for stones in obese patients, its safety and success has not been fully elucidated. The current study describes the worldwide prevalence of obesity in patients with urolithiasis and examines trends in URS outcomes, safety, and efficacy.
Methods: This study utilized the Clinical Research Office of the Endourological Society (CROES) URS Global Study, which was a prospective, multicenter study including 11,885 patients treated with URS for urinary stones at 1 of 114 urology departments across 32 countries.